"The
Report Inclusion Body Myositis (IBM) - Pipeline Review, H1 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Global Markets Directs,
Inclusion Body Myositis (IBM) - Pipeline Review, H1 2016, provides an
overview of the Inclusion
Body Myositis (IBM)
pipeline landscape.
The report provides
comprehensive information on the therapeutics under development for
Inclusion Body Myositis (IBM), complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Inclusion Body Myositis (IBM) and
features dormant and discontinued projects.
Global Markets Directs report
features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Drug profiles featured in the report undergoes
periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
The report helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.
Download Sample copy of this
Report at : http://www.marketresearchreports.biz/sample/sample/726770
Scope
- The report provides a
snapshot of the global therapeutic landscape of Inclusion Body
Myositis (IBM)
- The report reviews pipeline
therapeutics for Inclusion Body Myositis (IBM) by companies and
universities/research institutes based on information derived from
company and industry-specific sources
- The report covers pipeline
products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- The report features
descriptive drug profiles for the pipeline products which includes,
product description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key
players involved Inclusion Body Myositis (IBM) therapeutics and
enlists all their major and minor projects
- The report assesses Inclusion
Body Myositis (IBM) therapeutics based on drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the
dormant and discontinued pipeline projects
- The report reviews latest
news related to pipeline therapeutics for Inclusion Body Myositis
(IBM)
Reasons to buy
- Gain strategically
significant competitor information, analysis, and insights to
formulate effective R&D strategies
- Identify emerging players
with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Identify and understand
important and diverse types of therapeutics under development for
Inclusion Body Myositis (IBM)
- Identify potential new
clients or partners in the target demographic
- Develop strategic initiatives
by understanding the focus areas of leading companies
- Plan mergers and acquisitions
effectively by identifying key players and its most promising
pipeline therapeutics
- Devise corrective measures
for pipeline projects by understanding Inclusion Body Myositis (IBM)
pipeline depth and focus of Indication therapeutics
- Develop and design
in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand
business potential and scope
- Modify the therapeutic
portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report
Coverage 6
Inclusion Body Myositis (IBM)
Overview 7
Therapeutics Development 8
Pipeline Products for Inclusion
Body Myositis (IBM) - Overview 8
Pipeline Products for Inclusion
Body Myositis (IBM) - Comparative Analysis 9
Inclusion Body Myositis (IBM) -
Therapeutics under Development by Companies 10
Inclusion Body Myositis (IBM) -
Therapeutics under Investigation by Universities/Institutes 11
Inclusion Body Myositis (IBM) -
Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Inclusion Body Myositis (IBM) -
Products under Development by Companies 15
Inclusion Body Myositis (IBM) -
Products under Investigation by Universities/Institutes 16
Inclusion Body Myositis (IBM) -
Companies Involved in Therapeutics Development 17
Acceleron Pharma, Inc. 17
Escala Therapeutics, Inc. 18
Milo Biotechnology LLC 19
Nobelpharma Co., Ltd. 20
Novartis AG 21
Orphazyme ApS 22
Ultragenyx Pharmaceutical Inc.
23
Inclusion Body Myositis (IBM) -
Therapeutics Assessment 24
Assessment by Monotherapy
Products 24
Assessment by Target 25
Assessment by Mechanism of
Action 27
Assessment by Route of
Administration 29
Assessment by Molecule Type 31
Drug Profiles 33
AAV1-Foliistatin - Drug Profile
33
Product Description 33
Mechanism of Action 33
R&D Progress 33
ACE-083 - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
aceneuramic acid - Drug Profile
35
Product Description 35
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment